BerandaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Tutup sebelumnya
₹1.644,00
Rentang hari
₹1.577,90 - ₹1.664,05
Rentang tahun
₹702,75 - ₹1.997,40
Kapitalisasi pasar
81,15Â M INR
Volume Rata-Rata
67,26Â rb
Rasio P/E
66,79
Hasil dividen
-
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 2,23Â M | 12,05% |
Biaya operasional | 698,25Â jt | 14,56% |
Laba bersih | 272,36Â jt | 37,53% |
Margin laba bersih | 12,23 | 22,79% |
Penghasilan per saham | 5,37 | — |
EBITDA | 302,47Â jt | 30,11% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,44Â M | 384,25% |
Total aset | 16,35Â M | 9,59% |
Total liabilitas | 4,11Â M | 6,94% |
Total ekuitas | 12,24 M | — |
Saham yang beredar | 50,72 jt | — |
Harga terhadap nilai buku | 6,81 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 4,03% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 272,36Â jt | 37,53% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Didirikan
1992
Situs
Karyawan
871
